India is known as the Pharmaceutical for the World. India has been developing Vaccines for more than 30 years. India has emerged as one of the leading manufacturers of vaccines worldwide, and supplies large quantities of basic and advanced vaccines across the globe – 60% of global vaccine.
So why is Pfizer withdrawing their application from the worlds 2nd largest population?
Did India ask the right question?
Was Pfizer unable to provide the required data? According to the article, Pfizer’s response was - " Pfizer will continue to engage with the authority and re-submit its approval request with additional information as it becomes available in the near future.”
India's Central Drugs Standard Control Organisation had declined to accept Pfizer's request for approval without a small local trial on the vaccine's safety and immunogenicity for Indians
Isn’t this a requirement in most countries? To have a local trial on the vaccine safety and immunogenicity .
According to Malaysian Rubber Glove Manufactuters Association (MARGMA), global glove demand is about 330 billion pieces per year & estimated to grow at 10% annually
For 2021 global glove demand is expected to grow to 396 billion pieces versus the total production capacity of Malaysian glove factories of 280 billion pieces
While for 2022 global glove demand is expected to expand further to 475 billion pieces against the projected total production capacity of Malaysian glove factories of 363 billion pieces
While also, a research analyst from a local IB has also written that covid-19 vaccine deployment could in fact add another further new demand source of 18 billion pieces per year, assuming that 60% of the world's 7.5 billion people gets their vaccine in two doses annually
Today, the demand for rubber gloves is so overwhelming that major rubber glove manufacturers have an order waiting list of more than 12 months, a few extending to twenty four months, some up to even thirty six months
Fourteen residents at a German nursing home have tested positive despite receiving two vaccine doses.
Local officials in the district of Osnabruck, Germany, said there was an outbreak of the UK variant of coronavirus at a nursing home in Belm. The outbreak came despite all of its residents already receiving two doses of the BioNTech-Pfizer vaccine, with their last shot on January 25. A local government spokesperson said 14 residents tested positive for the virus at the end of last week So it seemed that the Pfizer vaccine even after 2 doses is not effective against the UK Virus Variant.
Is the Vaccination program failing?
Why did Pfizer pull out from India, the World’s 2nd largest population when India requested for trial. ? .
The country now reports 944 cases of variants that spread more easily, bypass treatments and immunities, or both
Tuesday night's report still shows three known cases of P.1, a variant first spotted in Brazil that appears to bypass immunities, and now nine cases of B.1.351, a variant that took over South Africa and resists some treatments and vaccines
@pzgro- from history , good QR report means the share price will dive ! I wish it isn’t true but it’s happened again and again. Will Careplus give dividend this year?
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
strattegist
23,459 posts
Posted by strattegist > 2021-02-05 16:04 | Report Abuse
soft